Group program to improve health for people with Type 2 Diabetes
Official title: Dando Pasos Juntos: An Integrative Group Program for Type 2 Diabetes Mellitus
Run by TecSalud Investigación Clínica · NCT05888454 · Data updated 2026-05-14
This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.
This study is testing a group program that combines health coaching and education to see if it helps people with Type 2 Diabetes feel better and manage their condition more effectively.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 80 Years |
| Sex | All |
| Enrollment | 120 (estimated) |
| Sponsor | TecSalud Investigación Clínica Academic / other |
| Locations | 2 sites (San Pedro Garza Garcia, Nuevo León and 1 other locations) |
| Trial ID | NCT05888454 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 to 80 with a recent diagnosis of Type 2 Diabetes and residing in Nuevo León, México.
✕Probably not a fit
Patients currently on insulin treatment or with a diagnosis of Type 2 Diabetes for more than five years may not benefit from this program.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This open, randomized, controlled trial aims to evaluate the effects of an integrative group program on metabolic control and the perception of wellbeing in patients with Type 2 Diabetes Mellitus (T2DM). The program includes six in-person sessions led by a health coach, occurring bi-weekly, along with six asynchronous educational sessions over a 12-week period. Participants will receive both the integrative program and conventional treatment for T2DM to assess the combined impact on their health outcomes.
Why it matters
Potential benefit: If successful, this program could enhance metabolic control and improve the overall wellbeing of patients with Type 2 Diabetes.
How similar studies have gone: Previous studies have shown positive outcomes with integrative approaches for managing Type 2 Diabetes, suggesting potential success for this program.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * T2DM diagnosis of less than 5 years * Age 18 to 80 years * Current residence in Nuevo León, México * Availability to attend in-person sessions * Provides written informed consent * Able to read and write Exclusion Criteria: * Currently under insulin treatment * T2DM diagnosis more than 5 years ago * Comorbidities such as active cancer, acquired immunodeficiency (HIV+, AIDS), liver, cardiovascular, renal, pulmonary or thyroid disease. * History of severe neurologic or psychiatric disease (current or past diagnosis) * Currently pregnant or intention of pregnancy in the following 3 months * Males that consume more than 4 alcoholic beverages daily or 14 weekly * Females that consume more than 3 alcoholic beverages daily or 7 weekly * Consumption of any illicit drug
Where it's running
-
Centro Médico Zambrano Hellion, Fundación Santos y de la Garza Evia I.B.P, TecSalud
San Pedro Garza Garcia, Nuevo León, Mexico Recruiting -
Centro de Salud Integral, Fundación Santos y de la Garza Evia I.B.P, TecSalud
Santa Catarina, Nuevo León, Mexico Recruiting
Study contacts
- Principal investigator: Tania Zertuche, MD — Director de Instituto de Bienestar y Prevención
- Study coordinator: Regina Moreno, MD
- Email: regina.moreno@tecsalud.mx
- Phone: +52 33 367 668 77
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Proliverenol for liver fat and insulin resistance in type 2 diabetes
This study tests whether adding Proliverenol to standard diabetes care can improve liver fat and blood sugar control in adults with type 2 diabetes.
-
Whole-Body Vibration Training in Women With Obesity With and Without Type 2 Diabetes
This study tests whether eight weeks of supervised whole-body vibration training changes ankle muscle activity and walking performance in women with obesity, comparing those with and without type 2 diabetes.
-
Safety test of NNC9836-0001 in adults with overweight/obesity or type 2 diabetes
This study tests whether the new medicine NNC9836-0001 is safe and tolerable in adults who are overweight or have type 2 diabetes, compared to placebo.
-
RIGHTEST iFree 2 CGM in Pregnant Women With Diabetes
This study tests the accuracy and safety of the RIGHTEST iFree 2 continuous glucose monitor in pregnant adults with type 1, type 2, or gestational diabetes.
-
EloraTZP for weight loss in adults with overweight/obesity and type 2 diabetes
This trial tests whether a coformulation of eloralintide and tirzepatide helps people with obesity or overweight and type 2 diabetes lose weight compared with tirzepatide alone.
-
Maridebart cafraglutide vs. semaglutide for type 2 diabetes on metformin
This trial tests whether maridebart cafraglutlide is as good as semaglutide at improving blood sugar in adults with type 2 diabetes who take metformin (with or without an SGLT-2 inhibitor).
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.